We observed that the patient's tumor post-TKIs, which is the origin of GIST-RX1 and TKI-resistant, was negative for PTEN IHC, whereas the patient's tumor tissue at diagnosis prior to TKIs was positive for PTEN IHC (Figure 2). The gene discussed is PTEN; the disease is gastrointestinal stromal tumor.